本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

1.13
-0.0143-1.25%
盘后1.130.00000.00%16:15 EDT
成交量:1.69万
成交额:1.92万
市值:3,638.18万
市盈率:-0.68
高:1.15
开:1.14
低:1.11
收:1.15
数据加载中...
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC问询函

[Cover]Correspondence
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15

招股说明书

Registration statement for certain foreign private issuers
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

SEC问询函

[Cover]Correspondence
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

招股说明书

Registration statement for certain foreign private issuers
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]